Adcock Ingram Integrated Report 2018

Stakeholder group Stakeholder needs and expectations Stakeholder contribution to value creation Means of engagement with stakeholders Communities Ongoing commitment and support towards projects considering the interests and needs of the communities in which we operate. Interaction with the communities affords us an opportunity to understand and contribute to their needs. Interaction through the Company’s corporate social initiatives as well as various initiatives undertaken by each operating division. Shareholders, investor community and analysts Open and transparent in communication. Implement our business strategy and structure the business optimally for sustainable returns whilst managing risk, identify growth opportunities and have good governance practices. Keep up to date on the organisation’s financial and operational performance. Shareholders are encouraged to attend Adcock Ingram’s annual general meeting and to directly discuss relevant issues with management. We communicate regularly through the Johannesburg Stock Exchange (JSE), press releases, telephonic and face-to- face meetings. Multinational partners and licensors Building their brands utilising our marketing expertise, and sales and distribution network which offers a flexible service on a national basis through our significant critical mass and reach with healthcare professionals. Achievement of commercial goals; alignment with international best practice standards for product promotion and regulatory adherence. Partnerships are embedded with marketing and distribution agreements on established brands. Allows the Company to enter or expand into therapeutic categories. Regular commercial reviews with partners. Combined attendance and promotion at conferences and congresses to share best practice with relevant parties. Suppliers and service providers Conduct business in an open, honest and transparent manner that is mutually beneficial and sustainable, including timeous payments and fair terms. By providing good quality raw materials and finished products in line with pharmaceutical standards, in a timely manner assist in avoiding stock outs of products. Suppliers aligned to the country’s B-BBEE imperatives and also focus on emerging enterprises and black women owned businesses, assist Adcock Ingram with its focus areas of transformation. Supplier relationship management is implemented through personal contact and consistent interaction at operational and management levels. Industry bodies Membership and participation to contribute towards an industry viewpoint and response on regulatory issues and health policy. Influence policies that create a sustainable local manufacturing pharmaceutical industry and serve the healthcare needs of South Africa. Keep abreast of regulatory and industry issues so that the Company can have a relevant position on matters. Membership and participation in: Pharmaceuticals Made in South Africa (PHARMISA); Self Medication Association of South Africa (SMASA); the Pharmaceutical Task Group (PTG) and the Marketing Code Authority (MCA). Media Good corporate citizenship through transparent and responsible reporting and disclosure The media contributes in sustaining our brand reputation and increase awareness of new products, industry development and regulatory challenges. Press releases, media interviews and reactive responses, and SENS announcements ADCOCK INGRAM  Integrated Report 2018 43